CannaTech

MAY 16, 2019

CannaTech Tel Aviv 2019 was an absolute sensation, and we are already looking to Cape Town for our next big event. Kassi is equipped for advanced data collection, offering accurate, real-time, shareable dispensing history, automated reminders and personal recommendations. MMJGRIND: easy to grip, easy to maintain, pure medicine.

Data 13

Data Collective Consumption Treatment 13

Canna Law Blog

JULY 12, 2020

Here is a report from Penn Medicine back in 2017 on this same topic. In November 2019, Leafly compiled a ton of data on the inaccurate labels of many CBD products. There is potential for adverse events by having higher CBD concentrations than expected, resulting in changing serum antiepileptic levels.

CBD 61

CBD Data Edibles Hemp 61

Cannabis Law Report

AUGUST 23, 2021

In testimony before the US Senate in July 2019, Dr. Amy Abernethy, Principal Deputy Commissioner at FDA, stated that the Agency recognizes the need for “regulatory clarity, particularly given the significant public interest in hemp products, and CBD in particular.” Who’s responsible for regulating CBD in pet products?

Pets 105

Pets Hemp CBD Food 105

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. These treatments can be prescribed only by specialist doctors in a limited number of circumstances where other medicines have failed. September 23, 2019. What do experts say?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

JULY 4, 2019

The programme aims to investigate mechanisms of action of cannabis-based medicinal products related to several clinical applications including pain and cancer, as well as characterise cannabis-based medicinal products in disease models with particular focus of chronic pain, spasticity and cancer. About Imperial College London.

Cannabinoids 40

Cannabinoids Clinical Trials Chronic Pain Medicine 40

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JULY 2, 2021

According to a study by Data Bridge Market Research, the global market for psychedelics is growing and will reach a value of over $6 billion within the next five years, compared to $2 billion in 2019. According to the firm, Doug Drysdale, the CEO of the company, would take part in a fireside chat at the event. NASDAQ: MNMD).

Research and Development 105

Research and Development Treatment Therapy Medicine 105

Freedom Leaf

JANUARY 4, 2018

After months of development, my partner and I built and successfully launched the beta for our cannabis data-analytics software, Jade Insights. It’s a software platform that helps cannabis businesses augment their process by providing insights for data-backed decision-making. ” JOHN KAGIA. ” OPHELIA CHONG.

Data 60

Data Policy Media Cannabis 60

Cannabis Law Report

SEPTEMBER 20, 2019

Data indicates cannabis-containing vaping products losing market share to other cannabis products after recently reported health concerns. This represents a 30 percent increase from the 2019 cannabis quota. The Hot Box Lounge will be Colorado’s first licensed event cannabis consumption lounge. metric tons in Toronto.

Vaping 40

Vaping Banking Research and Development DEA 40

Cannabis Law Report

OCTOBER 9, 2019

Beyond Pesticides , October 8, 2019) As medicinal and recreational marijuana continue to be legalized in a growing number of states, concerns about the safety of the burgeoning industry—how the substance is grown, harvested, processed, distributed, sold, and used—have emerged. Here’s their blog post of 8 October.

Environment 55

Environment Safety Medicine Policy 55

Cannabis Law Report

JANUARY 20, 2022

Eleusis pioneers the development of psychedelic drug candidates in the life sciences space, with the goal of transforming psychedelics into broadly accessible medicines. Medicines and Healthcare products Regulatory Agency’s Innovative Licensing and Access Pathway (“ILAP”), offering the potential to accelerate time to market.

Therapy 52

Therapy Research and Development Business Access 52

Cannabis Law Report

NOVEMBER 23, 2019

As of Tuesday, 277 out of the 407 permits involved had not received reinstatement to “active” status, according to state licensing data. Announces Third Quarter 2019 Results. . Nov 22, 2019, 07:00 ET . — Third quarter 2019 revenue of $14.1 ” 2019 Guidance (2). ” 2019 Guidance (2).

Legalization 59

Legalization Retail Research and Development Cultivation 59

MassRoots

AUGUST 4, 2020

Virgin Islands have enacted either medicinal or recreational legalization amendments. Further, data from 2019 indicates that only 200 Latinx and Black individuals nationwide were able to raise over $1 million in venture capital. The events of recent months have shown us that this bill is more important than ever.

Banking 52

Banking Access Business Programs 52

Cannabis Law Report

JANUARY 27, 2020

In Europe, probably more than in any other part of the world, safety is taken incredibly seriously – and has often been used time and time again to banish non-medicinal products and supplements from the market, irrespective of the benefits they might provide to citizens. Inevitably, this is an area we’re watching very closely.

Safety 59

Safety CBD Food Seed-To-Sale 59

SpeedWeed

MARCH 7, 2021

Mark does have quite a bit to share with us, but as always, we’re going to check in with Ed to see what he’s uncovered this week from the data vault. This one was on the advisory sector, which focuses on consultants as well as essentially data analytics firms, so that was fun to dig back into that.

Extraction 52

Extraction Data Hemp Research and Development 52

Cannabis Law Report

OCTOBER 12, 2021

In November 2019 , the Company completed its initial public offering and listed its shares on the Canadian Securities Exchange. Hollister has since transformed from its pre-revenue position in late 2019 into a profitable multi-state cannabis operator. Background. This is an exciting time for me as a founder.

Extraction 52

Extraction Business Hash Events 52

CannaMD

SEPTEMBER 15, 2020

Where can you use your medicine and when are you at risk of getting arrested? After this data has been entered, the information will be reviewed and you will receive your medical marijuana card. MORE DETAILS: On April 20, 2019, the U.S. This includes items that are used for medicinal purposes. What about travel?

Law 126

Law Marijuana Patients Treatment 126

SpeedWeed

APRIL 28, 2021

“What ended up happening was that the company had sent over some workers from different locations because this is a purely medicinal facility [in Hanover] and the [adult-use] locations for Curaleaf had closed,” Local 328 Director of Organizing Sam Marvin said. “So, And, so, essentially that made up some of the challenged votes.”.

Seed-To-Sale 52

Seed-To-Sale Dispensary Cultivation Food 52

SpeedWeed

APRIL 28, 2021

“What ended up happening was that the company had sent over some workers from different locations because this is a purely medicinal facility [in Hanover] and the [adult-use] locations for Curaleaf had closed,” Local 328 Director of Organizing Sam Marvin said. “So, And, so, essentially that made up some of the challenged votes.”.

Legalization 52

Legalization Seed-To-Sale Dispensary Cannabis 52

SpeedWeed

APRIL 27, 2021

“What ended up happening was that the company had sent over some workers from different locations because this is a purely medicinal facility [in Hanover] and the [adult-use] locations for Curaleaf had closed,” Local 328 Director of Organizing Sam Marvin said. “So, And, so, essentially that made up some of the challenged votes.”.

Seed-To-Sale 52

Seed-To-Sale Dispensary Cannabis Cultivation 52

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. In 2021, CBD sales in the natural channel totaled $38,931,696, a 24% decline.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

DECEMBER 8, 2019

Editor’s note: The American Journal of Endocannabinoid Medicine (AJEM) is the only printed, peer-reviewed, medical cannabis journal in North America. AJEM’s mission is to create, collect, and disseminate credible cannabis research data. On the one hand, cannabinoids produced by cannabis clearly have medicinal benefits.3-5

Medicine 59

Medicine Research and Development Food Cannabinoids 59

SpeedWeed

APRIL 29, 2021

“What ended up happening was that the company had sent over some workers from different locations because this is a purely medicinal facility [in Hanover] and the [adult-use] locations for Curaleaf had closed,” Local 328 Director of Organizing Sam Marvin said. “So, And, so, essentially that made up some of the challenged votes.”.

Programs 52

Programs Seed-To-Sale Dispensary Cultivation 52

Cannabis Law Report

SEPTEMBER 12, 2021

I was sworn into a term on the NCUA Board in 2019—having served as chairman until January of this year — but this is actually my second term of service on the Board. Looking at the data from the Treasury Department’s Financial Crimes Enforcement Network (opens new window) , or FinCEN, as of the end of last year there were only 515 U.S.

Banking 89

Banking Law Legalization Hemp 89

Cannabis Law Report

NOVEMBER 7, 2019

Cannatrek’s Seed to Patient business model combines cutting edge cultivation expertise and world class manufacturing practices to deliver high quality medicinal cannabis oil formulations and medicinal strains of dried flowers at a significantly lower cost to patients and retailers.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. Focusing on professional medical publications, this study sought to investigate how medicinal cannabis is being represented in professional medical publications. The precis is simple. Background. Conclusions. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

OCTOBER 24, 2021

What used to be considered an illicit drug in most countries is now a decriminalized plant with some medicinal potential. Specifically, we will discuss the challenges and key considerations when attempting to quantify the lost profits that can arise from either first-party exposure from an insured event or third-party claims.

Strains 52

Strains Edibles Extraction Vaping 52

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. Event details below: Date: Tuesday, September 17th 2019. MONTREAL and SMITHS FALLS, ON, Sept. Time: 9:00AM to 5:00PM.

Programs 108

Programs Research and Development Education Treatment 108

Project CBD

MAY 3, 2023

She is also the author of Cannabis is Medicine: How Medical Cannabis and CBD are Healing Everything from Anxiety to Chronic Pain. It’s noteworthy that much of this anecdotal data is supported by findings from preclinical research. Remember, the pharmaceutical model is “this medicine addresses this specific target.”

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Cannabis Law Report

OCTOBER 26, 2019

Devices that are used to administer medicines, for example a transdermal patch containing medicine, are regulated as a medicine rather than a medical device. The TGA provides guidance on the appropriate classification of products that are on the device-medicine boundary.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Veriheal

MAY 18, 2021

Dr. Joseph Palamar is an associate professor at NYU Grossman School of Medicine, an affiliated researcher with the Center for Drug Use and HIV/HCV Research at NYU School of Global Public Health, and the lead author in this study. These participants responded to the survey on the National Survey on Drug Use and Health between 2015 to 2019.

Consumption 62

Consumption Data Vaping Retail 62

Cannabis Law Report

JANUARY 23, 2020

Additionally, Business and Professions Code section 26013(b) deems the adoption of emergency regulations by a licensing authority to implement the Medicinal and Adult-Use Regulation and Safety Act (MAUCRSA) as an emergency and necessary for the immediate preservation of the public peace, health, safety, or general welfare. 14, 2019).

Vaping 64

Vaping THC Retail Safety 64

The Joint Blog

APRIL 21, 2020

This is according to a study published in the Journal of Clinical Medicine Research and epublished by the U.S. ” “[M]ost studies reported no adverse events with acute administration and mild to moderate adverse effects with chronic administration. National Institute of Health.

Clinical Trials 52

Clinical Trials CBD Safety Patients 52

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. Event details below: Date: Tuesday, September 17th 2019. MONTREAL and SMITHS FALLS, ON, Sept. Time: 9:00AM to 5:00PM.

Programs 40

Programs Research and Development Education Treatment 40

Puff Puff Post

NOVEMBER 5, 2019

5, 2019 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. VANCOUVER, Nov.

Clinical Trials 40

Clinical Trials Pharmaceutical Cannabinoids Data 40

CannaMD

MARCH 8, 2020

The study authors arrived at this estimate based on a series of user-response surveys, with the notation that “given the substantial non-response [to the survey questions] these data are subject to response bias.”. Acknowledging the limited scope of data, few mechanisms of cardiovascular risk have emerge. a heart attack).

Patients 79

Patients Marijuana Research and Development Clinical Trials 79

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. published the first edition of the MAPS Bulletin , titled “ MDMA Can Become a Legal Medicine ,” and the FDA rejected the second MDMA study protocol submitted by MAPS.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52